≈$12.55B Army DEFINITIVE CONTRACT W58P0522C0001

DoD (Army contracting): ~$12.5B for 10M courses of an oral antiviral (PF-07321332) — a contract with Pfizer (USAspending)

Department of the Army ・2021-11-17 〜 2023-03-31

An Army contracting component awarded about $12.5B ($12,549,999,848) to Pfizer for 10 million courses of the oral protease inhibitor PF-07321332 (nirmatrelvir, the active component of Paxlovid). An example of the defense procurement system used for pandemic-response drug purchasing.

Contract key facts

RecipientPFIZER INC
Contract value$12,549,999,848 (≈$12.55B)
BranchArmy
Awarding agencyDepartment of Defense
Awarding sub-agencyDepartment of the Army
Award typeDEFINITIVE CONTRACT
Period of performance2021-11-17 〜 2023-03-31
Contract ID (PIID)W58P0522C0001

Contract scope (original)

AWARD OF 10M TREATMENT COURSES OF ORAL PROTEASE INHIBITOR PF-07321332

Key points

An Army contracting component procured 10M courses of an oral antiviral
PF-07321332 = nirmatrelvir = the active component of Paxlovid
Value ~$12.5B, period of performance November 2021–March 2023
The defense procurement system used for pandemic-response drug buying
Recipient: pharmaceutical leader Pfizer

This contract covers 10 million treatment courses of the oral protease inhibitor "PF-07321332." PF-07321332 is the development code name for nirmatrelvir, the active component of the COVID-19 oral treatment "Paxlovid" (Paxlovid combines nirmatrelvir with ritonavir).

What it shows is pandemic-response purchasing — distinct from defense itself — running through the DoD's (Army's) contracting machinery. In the COVID-19 response, the U.S. government used the DoD's procurement expertise for large-scale buying of drugs and supplies. The scale of 10 million courses reflects how, in an emergency, the government places huge, partly advance, single-vendor purchases. Pfizer is a global pharmaceutical leader (also covered in our company profiles).

Why it matters

A concrete example of the DoD's contracting machinery used for pandemic-response drug purchasing. Useful for understanding emergency government procurement and the scale of public-private vaccine/therapeutic supply.

FAQ

What data is this?

A single Department of Defense (DoD) federal procurement contract recorded in "USAspending," the U.S. open government-spending dataset. The recipient, awarding component, value, and scope are public. This site is not an official U.S. government website.

What is PF-07321332?

The development code name for nirmatrelvir, the active component of the COVID-19 oral treatment "Paxlovid" (which combines nirmatrelvir with ritonavir).

Why would the "Army" buy a drug?

In the COVID-19 response, the U.S. government used the DoD's (Army's) procurement expertise for large-scale buying of drugs and supplies. This contract is one example.

Sources (primary)

This article is an independent organization based on the U.S. official spending data below. Verify the exact, latest details with the official source.

USAspending (award details)
Contract ID (PIID)：W58P0522C0001

#Defense#Department of Defense#Army#Pharmaceuticals#Pandemic response#Federal procurement

← Back to the defense ranking